Provider-Administered Drug Policies (Excluding Oncology) - Blue Advantage

Provider-administered drug policies are based on (i) information in FDA approved package inserts (and black box warning, alerts, or other information disseminated by the FDA as applicable); (ii) research of current medical and pharmacy literature; and/or (iii) review of common medical practices in the treatment and diagnosis of disease as of the date hereof.

Use the navigation on the left to view our current, draft and previous pharmacy policies. Draft policies are available for provider comment for 45 days from the posting date listed on the policy. We encourage practicing physicians to provide input.